BISKER-LEIB VERED (Chief Operating Officer) received a stock award from COMPASS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/10/2024ACC: 0001171843-24-000179
Officer· Chief Operating Officer
Since Jun 2020
+3.51M
Net shares
Net buyer
$3.38M
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
3.51M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.75M
Price / share
$1.93
Trade value
$3.38M
% of position
123.4%
1/9/2024
1.42M→3.17M
Total
Net shares
+1.75M
Net value
$3.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2024 | A · Award | +1.75M | $1.93 | $3.38M | 123.4% | 1.42M | 3.17M |
| Total | +1.75M | $3.38M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
CommonStock
1.75M shares
Shares
+1.75M
Strike price
1.93
Held after
1.75M
Exercisable
—
1/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | CommonStock1.75M shares | 1/9/2024 | A · Award | +1.75M | 1.93 | — | 1.75M |